NWL
57
3
XRAY
28
3
EXC
53
3
MU
79
3
FTI
61
-2
NEM
69
-2
VLO
40
-2
UA
38
3
HSY
50
5
PFE
38
2
CPB
37
2
PVH
30
2
BK
77
2
TGT
52
2
PX
55
2
ZBH
45
3
MSI
47
-2
PSA
37
2
MAS
63
3
EXR
26
2
NWL
57
3
XRAY
28
3
EXC
53
3
MU
79
3
FTI
61
-2
NEM
69
-2
VLO
40
-2
UA
38
3
HSY
50
5
PFE
38
2
CPB
37
2
PVH
30
2
BK
77
2
TGT
52
2
PX
55
2
ZBH
45
3
MSI
47
-2
PSA
37
2
MAS
63
3
EXR
26
2
Financhill
Back

Verrica Pharmaceuticals, Inc. Vs. Travere Therapeutics, Inc. Industry Stock Comparison

Buy
62

VRCA
Verrica Pharmaceuticals, Inc.

Last Price:
$8.36
Seasonality Move:
19.5%
Buy
80

TVTX
Travere Therapeutics, Inc.

Last Price:
$40.3200
Seasonality Move:
33.23%
Buy
62
Verrica Pharmaceuticals, Inc. (VRCA) is a Buy

Is Verrica Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Verrica Pharmaceuticals, Inc. [VRCA] share price is $8.33. The Score for VRCA is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • VRCA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
80
Travere Therapeutics, Inc. (TVTX) is a Buy

Is Travere Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Travere Therapeutics, Inc. [TVTX] share price is $40.2800. The Score for TVTX is 80, which is 60% above its historic median score of 50, and infers lower risk than normal.
  • TVTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

VRCA Stock Price Chart

What is Verrica Pharmaceuticals, Inc.'s stock price today?

  • The Verrica Pharmaceuticals, Inc. share price today is $8.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and VRCA is experiencing slight selling pressure.

TVTX Stock Price Chart

What is Travere Therapeutics, Inc.'s stock price today?

  • The Travere Therapeutics, Inc. share price today is $40.2800
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TVTX is experiencing slight buying pressure.

VRCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.14 Buy
Relative Strength Index (14 RSI): 60.86 Buy
Chaikin Money Flow: -3582 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.81 - 8.81) Buy
Bollinger Bands (100): (3.75 - 6.91) Buy

TVTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 9.67 Buy
Relative Strength Index (14 RSI): 69.35 Buy
Chaikin Money Flow: 1508490 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (34.0318 - 36.4718) Buy
Bollinger Bands (100): (20.7309 - 34.2909) Buy

VRCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 8.07 Buy
20-day SMA: 8.01 Buy
50-day SMA: 5.55 Buy
200-day SMA: 5.58 Buy
8-day EMA: 6.32 Buy
20-day EMA: 3.65 Buy
50-day EMA: 1.72 Buy
200-day EMA: 0.47 Buy

TVTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 35.7 Buy
20-day SMA: 35.23 Buy
50-day SMA: 33.43 Buy
200-day SMA: 22.2 Buy
8-day EMA: 28.52 Buy
20-day EMA: 16.32 Buy
50-day EMA: 7.67 Buy
200-day EMA: 2.09 Buy

Verrica Pharmaceuticals, Inc. Earnings Growth & VRCA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $13.64 per share, and a decrease next year of $1.96 per share.

Travere Therapeutics, Inc. Earnings Growth & TVTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.58 per share, and an increase next year of $1.08 per share.

Verrica Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Travere Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):